SUTRO BIOPHARMA, INC.
Financial highlights
| Metric | FY 12/31/25 | FY 12/31/24 | FY 12/31/23 | FY 12/31/22 | FY 12/31/21 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $102.5 | $62.0 | $153.7 | $67.8 | $61.9 |
| Operating income | -$158.4 | -$238.5 | -$89.3 | -$128.9 | -$98.5 |
| Net income | -$191.1 | -$227.5 | -$106.8 | -$119.2 | -$105.5 |
| Balance Sheet | |||||
| Total debt | — | — | $3.1 | $15.6 | $25.0 |
| Cash Flow Statement | |||||
| Free cash flow | -$177.2 | -$192.2 | -$111.8 | $3.3 | -$82.0 |
| Share repurchases | — | — | — | — | $<0.1 |
Shares outstanding 16.6M · Free float 56.9%
Annual filing data through FY ended December 31, 2025; float as of August 26, 2026.